Ning‐Fang Ma
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
Papers in
-
- RNA modifications and cancer 5
- Ubiquitin and proteasome pathways 5
- RNA Research and Splicing 4
- Oncology 9
- Cancer Cells and Metastasis 3
- Co-authors
- Xin‐Yuan Guan (15 shared papers)Dan Xie (7 shared papers)Olivier Déas (1 shared paper)Jing‐Ping Yun (2 shared papers)Liangping Xia (1 shared paper)Zhizhong Pan (2 shared papers)Rui‐Hua Xu (2 shared papers)Rixin Chen (2 shared papers)
- Journals
- Hepatology (3 papers)Cell Death and Disease (2 papers)Nature Communications (2 papers)Biomarker Research (1 paper)Cell Death Discovery (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Ning‐Fang Ma
29 papers receiving 1.5k citations
Ning‐Fang Ma's Hit Papers
Peers
Comparison fields: 5 of 96
- Cancer Research 622
- Toxicology 88
- Molecular Biology 1.1k
- Oncology 325
- Immunology 135
Countries citing papers authored by Ning‐Fang Ma
This map shows the geographic impact of Ning‐Fang Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning‐Fang Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning‐Fang Ma more than expected).
Fields of papers citing papers by Ning‐Fang Ma
This network shows the impact of papers produced by Ning‐Fang Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning‐Fang Ma. The network helps show where Ning‐Fang Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Ning‐Fang Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis Hit paper breakdown → | 2019 | 537 |
| 2 | 2008 | 139 | |
| 3 | 2009 | 134 | |
| 4 | 2005 | 131 | |
| 5 | 2007 | 125 | |
| 6 | 2010 | 110 | |
| 7 | 2021 | 54 | |
| 8 | 2017 | 54 | |
| 9 | 2021 | 26 | |
| 10 | 2016 | 26 | |
| 11 | 2021 | 18 | |
| 12 | 2009 | 16 | |
| 13 | 2018 | 14 | |
| 14 | 2018 | 14 | |
| 15 | 2017 | 13 | |
| 16 | 2021 | 12 | |
| 17 | 2021 | 10 | |
| 18 | 2016 | 9 | |
| 19 | 2019 | 9 | |
| 20 | 2016 | 6 |
About Ning‐Fang Ma
Ning‐Fang Ma is a scholar working on Molecular Biology, Oncology, Cancer Research, Public Health, Environmental and Occupational Health and Hepatology, having authored 29 papers that have together received 1.5k indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Ubiquitin and proteasome pathways (5 papers), RNA Research and Splicing (4 papers), Cancer Genomics and Diagnostics (4 papers), Reproductive Biology and Fertility (4 papers), Cancer Cells and Metastasis (3 papers), Ferroptosis and cancer prognosis (3 papers) and Liver physiology and pathology (3 papers). The work is most often cited by research in Cancer Research (622 citations), Toxicology (88 citations), Molecular Biology (1.1k citations), Oncology (325 citations) and Immunology (135 citations). Ning‐Fang Ma has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Xin‐Yuan Guan, Dan Xie, Olivier Déas, Jing‐Ping Yun, Liangping Xia, Zhizhong Pan, Rui‐Hua Xu, Rixin Chen, Xiaodan Ma and Kai Han. Their work appears in journals such as Hepatology, Cell Death and Disease, Nature Communications, Biomarker Research and Cell Death Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.